| Income Statement |
| Total Revenue | 1.23B |
|
| Revenues (USD) | 1.23B |
| Cost of Revenue | 619.29M |
| Gross Profit | 607.94M |
| Operating Expenses | 349.39M |
| Research and Development Expense | 84.62M |
| Selling, General and Administrative Expense | 263.27M |
| Operating Income | 258.55M |
| Income Tax Expense | 39.88M |
| Net Income | 235.70M |
| Net Income Common Stock | 235.70M |
| Net Income Common Stock (USD) | 235.70M |
| Consolidated Income | 235.70M |
| Earnings per Basic Share | 1.64 |
| Earnings per Basic Share (USD) | 1.64 |
| Earnings per Diluted Share | 1.63 |
| Earning Before Interest & Taxes (EBIT) | 275.58M |
| Earning Before Interest & Taxes (USD) | 275.58M |
| Weighted Average Shares | 143.50M |
| Weighted Average Shares Diluted | 145.04M |
| Balance Sheet |
| Cash and Equivalents | 1.75B |
| Cash and Equivalents (USD) | 1.75B |
| Trade and Non-Trade Receivables | 668.50M |
| Current Assets | 3.12B |
| Property, Plant & Equipment Net | 113.02M |
| Total Assets | 4.03B |
| Current Liabilities | 1.35B |
| Total Liabilities | 1.68B |
| Accumulated Retained Earnings (Deficit) | 3.60B |
| Accumulated Other Comprehensive Income | -112.24M |
| Shareholders Equity | 2.35B |
| Shareholders Equity (USD) | 2.35B |
| Assets Non-Current | 912.82M |
| Goodwill and Intangible Assets | 475.71M |
| Inventory | 491.74M |
| Liabilities Non-Current | 331.86M |
| Trade and Non-Trade Payables | 585.80M |
| Tax Liabilities | 92.55M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 18.98M |
| Net Cash Flow from Financing | -140.65M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.13M |
| Capital Expenditure | -16.80M |
| Issuance (Purchase) of Equity Shares | -105.01M |
| Net Cash Flow from Investing | -17.15M |
| Net Cash Flow - Investment Acquisitions and Disposals | -135.00K |
| Net Cash Flow from Operations | 166.71M |
| Effect of Exchange Rate Changes on Cash | -775.00K |
| Share Based Compensation | 29.63M |